Processa PharmaceuticalsPCSA
13F holders, Q4 2025 (December 31)10holders
$2.87avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Processa Pharmaceuticals Inc. (PCSA) in their 13F filings. The largest holders were Jane Street Group, LLC ($87K), Vanguard Group Inc. ($68K) and HRT Financial LP ($56K).
- Company
- Processa Pharmaceuticals Inc.
- CUSIP
- 74275C403
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $331K |
| Exits | 0 | $0 |
Ownership 10 holders
| Jane Street Group, LLC | 0.00% | New | 30,190 | $87K |
| Vanguard Group Inc. | 0.00% | New | 23,586 | $68K |
| HRT Financial LP | 0.00% | New | 19,691 | $56K |
| Geode Capital Management, LLC | 0.00% | New | 15,323 | $44K |
| UBS Group AG | 0.00% | New | 12,640 | $36K |
| Stonepine Capital Management, LLC | 0.03% | New | 12,323 | $35K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,390 | $4K |
| Bank of America Corp. | 0.00% | New | 18 | $52 |
| Jones Financial Companies LLLP | 0.00% | New | 7 | $20 |
| Wells Fargo & Company | 0.00% | New | 6 | $17 |
"% of holder's portfolio" is PCSA's weight in each manager's 13F, not the share of Processa Pharmaceuticals Inc. the manager owns.